These findings highlight the importance of individualized riskbenefit assessment when prescribing GLP-1 RAs, especially in people with underlying pancreatic vulnerability or elevated baseline risk
By improving insulin production, minimizing glucagon secretion, and impacting areas in the brain that control appetite, semaglutide can help reduce hunger and promote feelings of fullness
Vencio S, Vianna A, Silva M, Berbara T, Precoma D
Metabolic inflammation and insulin resistance in obesity
[143] revealed that vitamin D2 supplementation (40,000 IU per week) for 6 months decreased oxidative protein damage, improved quality of life and physical performance in osteoarthritis patients